LETTER
Hippokratia 2018, 22(2):93
Makis A, Tsabouri S, Chaliasos N
Child Health Department, Faculty of Medicine, University of Ioannina, Ioannina, Greece
Tag: cystic fibrosis
Vasoactive Intestinal Peptide Inhaled Agonists: Potential Role in Respiratory Therapeutics
ORIGINAL ARTICLE
Hippokratia 2013, 17(1):12-16
MathioudakisAG, Chatzimavridou-Grigoriadou V, Evangelopoulou E, Mathioudakis GA
Respiratory Assembly, Hellenic Sociery for the Advancement of Biomedical Research, Athens, Respiratory Department, General Hospital of Nikaia “St. Panteleimon”, Piraeus, Respiratory Department, IASO General Hospital, Athens, Greece
Use of lung clearance index to assess the response to intravenous treatment in cystic fibrosis
ORIGINAL ARTICLE
Hippokratia 2015, 19(1):47-52
Hatziagorou E, Avramidou V, Kirvassilis F, Tsanakas J
3rd Pediatric Department, Pediatric Pulmonology Unit, Aristotle University of Thessaloniki, Thessaloniki, Greece
Home intravenous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit
RSEARCH ARTICLE
Hippokratia 2016, 20(4):279-283
Chrysochoou EA, Hatziagorou E, Kirvassilis F, Tsanakas J
3rd Pediatric Department, Pediatric Pulmonology and Cystic Fibrosis Unit, Aristotle University of Thessaloniki, Hippokration Hospital, Thessaloniki, Greece
Results of active cycle of breathing techniques and conventional physiotherapy in mucociliary clearance in children with cystic fibrosis
Hippokratia 2007, 11(4):202-204
A. Hristara Papadopoulou, J. Tsanakas
Assessment of airway inflammation with exhaled NO measurement
Hippokratia 2007, 11(2):51-62
E Hatziagorou, J Tsanakas